TRANSCODE THERAPEUTICS, INC. Debt Instrument, Interest Rate, Stated Percentage
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Debt Instrument, Interest Rate, Stated Percentage of 6.00% as of 2021-02-14, per its 10-Q filed 2021-08-23.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2022-03-31
- 2021-02-14: Debt Instrument, Interest Rate, Stated Percentage 6.00%.
- 2020-05-31: Debt Instrument, Interest Rate, Stated Percentage 6.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2021-02-14 | 6.00% 10-Q · filed 2021-08-23 |
| 2020-05-31 | 6.00% 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |